For the Inventor, By the Inventor

Enter assignee name

Waltham, MA, United States of America

Scriptgen Pharmaceuticals, Inc.

Calculating rank

USPTO Granted Patents = 17

Forward Citations = 202

Loading Chart...

Loading Chart...

24 inventors (with patents filed for the assignee):

Mark A Wuonola (8 out of 11 patents)

Gary R Gustafson (6 out of 12 patents)

Jennifer V Schaus (4 out of 7 patents)

4. James S Panek (4 out of 7 patents)

5. Andrew A Pakula (3 out of 7 patents)

6. Tao Hu (3 out of 6 patents)

7. Zhe Li (3 out of 7 patents)

8. David G Powers (3 out of 3 patents)

9. James U Bowie (2 out of 12 patents)

10. John D Bradley (2 out of 37 patents)

11. Jaime E Arenas (2 out of 9 patents)

12. C Richard Wobbe (2 out of 11 patents)

13. James W Lillie (2 out of 7 patents)

14. Kelvin T Lam (2 out of 5 patents)

15. Yi Bin Xiang (2 out of 5 patents)

17 patents: Sort by Forward Citations

1. 6337183 - Screen for compounds with affinity for nucleic acids (2002-01-08),

2. 6335339 - Triazine antiviral compounds (2002-01-01),

3. 6194399 - Aryldiamine derivatives useful as antibacterial agents (2001-02-27),

4. 6165998 - Antifungal agents (2000-12-26),

5. 6140361 - Use of 2-deoxystreptamine as a molecular scaffold for the preparation of (2000-10-31),

6. 6127551 - Pyronin antibacterials, process and novel intermediates thereto (2000-10-03),

7. 6090953 - Pyronin antibacterials, process and novel intermediates thereto (2000-07-18),

8. 6051373 - Methods for screening for inhibitors of the transcription-enhancing (2000-04-18),

9. 6022983 - Pyronin antibacterials, process and novel intermediates thereto (2000-02-08),

10. 6020488 - Small molecule inhibition of RNA/ligand binding (2000-02-01),

11. 6004779 - Regulated gene expression in yeast (1999-12-21),

12. 5986111 - Pyronin antibacterials, process and novel intermediates thereto (1999-11-16),

13. 5942547 - 2-Deoxystreptamine derivatives, pharmaceutical compositions thereof and (1999-08-24),

14. 5760063 - Arylhydrazone derivatives useful as antibacterial agents (1998-06-02),

15. 5679582 - Screening method for identifying ligands for target proteins (1997-10-21),

Company Overview

Scriptgen Pharmaceuticals, Inc. is a biotechnology company based in Waltham, MA, specializing in the development of innovative therapeutics for various diseases. The company focuses on leveraging advanced drug discovery technologies to create novel treatments, particularly in the fields of oncology and rare diseases. With a commitment to scientific excellence, Scriptgen aims to address unmet medical needs through its proprietary platforms and collaborative research efforts, contributing to the advancement of healthcare solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

17 Patents

#86 in

#18,903 in

#35,948 in the World

Waltham, MA, United States of America

Scriptgen Pharmaceuticals, Inc.

Forward Citations = 202

24 inventors:

Mark A Wuonola (8 out of 11 patents)

Gary R Gustafson (6 out of 12 patents)

Jennifer V Schaus (4 out of 7 patents)

4. James S Panek (4 out of 7 patents)

5. Andrew A Pakula (3 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Scriptgen Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/scriptgen-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…